RVTY
REVVITY, INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$162.11
−0.84%Forward multiples
Based on analyst estimates
- P/E forward
- 28.05x
- P/E 2026E
- 29.51x
- P/E 2027E
- 26.81x
- P/E 2028E
- 24.46x
- P/S forward
- 6.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- 71.73x
- PEG TTM
- 0.45x
- Price / book
- 2.49x
- Price / sales
- 6.15x
- Price / cash flow
- 27.53x
Enterprise value
- Enterprise value
- $20.3B
- EV / sales
- 6.89x
- EV / EBITDA
- 25.72x
- EV / EBIT
- 54.45x
- Market cap
- $18.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Oct 1, 2026